Question 1

The factor that has the greatest effect on males developing male sexual characteristics is:&#10;A) Cultural beliefs&#10;B) Effective male role models&#10;C) Adequate intake of testosterone in the diet&#10;D) Androgen production

Accepted Answer

Androgen production is the factor that has the greatest effect on males developing male sexual characteristics. Androgens, such as testosterone, are the hormones that stimulate the development of primary and secondary male sexual characteristics, including the growth of the penis and testes, the deepening of the voice, and the growth of body hair. Cultural beliefs and effective male role models may have some influence on male sexual development, but they are not the primary factor. Adequate intake of testosterone in the diet is also important, but it is not the greatest determining factor in male sexual development.

Question 2

The goal of testosterone replacement therapy is:&#10;A) Absence of all hypogonadism symptoms&#10;B) Testosterone levels in the mid-normal range 1 week after an injection&#10;C) Testosterone levels in the mid-normal range just prior to the next injection&#10;D) Avoidance of high serum testosterone levels during therapy

Accepted Answer

Testosterone levels in the mid-normal range 1 week after an injection

Question 3

Men who are prescribed phosphodiesterase type 5 (PDE-5)inhibitors for erectile dysfunction should be educated regarding the adverse effects of the drug which include:&#10;A) Hearing loss&#10;B) Hypotension&#10;C) Delayed ejaculation&#10;D) Dizziness

Accepted Answer

Hearing loss

Question 4

Some research supports that testosterone replacement therapy may be indicated in which of the following diagnoses in men?&#10;A) Age-related decrease in cognitive functioning&#10;B) Metabolic syndrome&#10;C) Decreased muscle mass in aging men&#10;D) All of the above

Accepted Answer

Testosterone replacement therapy may be indicated in all of the listed diagnoses in men. Age-related decrease in cognitive functioning has been linked to low testosterone levels, and some studies have suggested that testosterone replacement therapy may improve cognitive performance. Metabolic syndrome, which includes high blood pressure, high blood sugar, abnormal cholesterol levels, and excess body fat around the waist, is also associated with low testosterone levels, and testosterone replacement therapy may improve these markers. Decreased muscle mass in aging men is a well-known consequence of low testosterone levels, and testosterone replacement therapy can help to preserve or increase muscle mass in these individuals.

Question 5

When assessing a male for hypogonadism prior to prescribing testosterone replacement,serum testosterone levels are drawn:&#10;A) Without regard to time of day&#10;B) First thing in the morning&#10;C) Late afternoon&#10;D) In the evening

Accepted Answer

Testosterone levels fluctuate throughout the day and are typically highest in the morning. Therefore, the most accurate assessment of a male's baseline testosterone levels is obtained by drawing blood first thing in the morning.

Question 6

Monitoring of male patients who are using phosphodiesterase type 5 (PDE-5)inhibitors includes:&#10;A) Serum fasting glucose levels&#10;B) Cholesterol and lipid levels&#10;C) Blood pressure&#10;D) Complete blood count

Accepted Answer

Monitoring blood pressure is important in patients who are using PDE-5 inhibitors, as these medications can cause a decrease in blood pressure, particularly in combination with nitrates. Monitoring fasting glucose levels, cholesterol and lipid levels, or complete blood count are generally not necessary in patients who are using PDE-5 inhibitors unless there is a specific medical indication to do so.

Question 7

Male patients who should not be prescribed phosphodiesterase type 5 (PDE-5)inhibitors include:&#10;A) Diabetics&#10;B) Those who have had an acute myocardial infarction in the past 6 months&#10;C) Patients who are deaf&#10;D) Patients under age 60 years of age

Accepted Answer

Patients who have had an acute myocardial infarction in the past 6 months should not be prescribed PDE-5 inhibitors due to the risk of cardiovascular complications. Patients with diabetes and those who are deaf may be prescribed PDE-5 inhibitors, as long as they do not have any contraindications. Age is not a determining factor in whether or not to prescribe PDE-5 inhibitors.

Question 8

While on testosterone replacement,hemoglobin and hematocrit levels should be monitored.Levels suggestive of excessive erythrocytosis or abuse are:&#10;A) Hemoglobin 14 g/dl or hematocrit 39%&#10;B) Hemoglobin 11.5 g/dl or hematocrit 31%&#10;C) Hemoglobin 13 g/dl or hematocrit 38%&#10;D) Hemoglobin 17.5 g/dl or hematocrit 54%

Accepted Answer

Hemoglobin levels greater than 17.5 g/dl or hematocrit levels greater than 54% suggest excessive erythrocytosis and may be indicative of testosterone abuse. It is important to monitor these levels to ensure patient safety and prevent potential adverse effects such as thromboembolic events.

Question 9

When prescribing phosphodiesterase type 5 (PDE-5)inhibitors such as sildenafil (Viagra)patients should be screened for use of:&#10;A) Statins&#10;B) Nitrates&#10;C) Insulin&#10;D) Opioids

Accepted Answer

Patients should be screened for use of nitrates, as concurrent use of PDE-5 inhibitors and nitrates can lead to severe hypotension and cardiovascular events. Statins, insulin, and opioids do not have significant drug interactions with PDE-5 inhibitors.

Question 10

Monitoring of an older male patient on testosterone replacement includes:&#10;A) Oxygen saturation levels at every visit&#10;B) Serum cholesterol and lipid profile every 3 to 6 months&#10;C) Digital rectal prostate screening exam at 3 and 6 months after starting therapy&#10;D) Bone mineral density at 3 months and 6 months after starting therapy

Accepted Answer

The answer of Monitoring of an older male patient on...

Deck 49: Men As Patients